To explore the clinical implications of the dysregulated lncRNAs, first, we analyzed the gene expression profiling of AML collected at diagnosis, and compared the expression of FTO, LIN892, LIN989, PROX1-AS1 and SENCR among different response groups. The gene discussed is PROX1; the disease is acute myeloid leukemia.